PATHOLOGIC SIGNIFICANCE OF BLOOD VOLUME CHANGES IN UNTREATED POLYCYTHEMIA VERA AND AFTER P$sup 32$ THERAPY (in Hungarian)
Ten patients suffering from polycythemia vera were divided into three groups for evaluation purposes. The first group (2 patients) consisted of the mildest cases in which the hematocrit values were 55% or less. The second group (2 patients) had a hematocrit values of 55% or higher, and the red cell and plasma voiumes were higher than normal. The third group consisted of the severest cases with hematocrit values of 70 to 80%, red cell counts of 6 to 8 million/ mm/sup 3, and red cell and plasma volumes two to four times normai. Blood volumes were determined with /sup 32/P or /sup 51/Cr. The patients showed clinical improvement after the first treatment with /sup 32/P and hematologic examination indicated that the red cell count dropped, while hemogiobin value, white cell count, thrombocyte count, and hematocrit decreased. After the second / sup 32/P treatment the blood volume did not decrease appreciably, but plasma volume increased, leading to improvement of the patient's condition. Venesection may still be used as a therapeutic means when an immediate reduction of the blood volume is desired. This can be achieved by /sup 32/P therapy only after severai treatments. The /sup 32/P dose varied with the severity of the illness from one treatment of five mC /sup 32/P in the patients with hematocrits of 55% to two doses of 4.2 mC in those with values of 58%, and three mC /sup 32/P in another patient with a hematocrit of 82%. (BBB)
- Research Organization:
- Orvostudomanyi Egyetem, Pecs, Hungary
- NSA Number:
- NSA-18-019661
- OSTI ID:
- 4018228
- Journal Information:
- Orv. Hetilap, Vol. Vol: 103; Other Information: Orig. Receipt Date: 31-DEC-64
- Country of Publication:
- Country unknown/Code not available
- Language:
- Hungarian
Similar Records
COMPARATIVE DETERMINATION OF BLOOD VOLUME WITH EVANS BLUE AND Cr$sup 51$ IN HEALTHY SUBJECTS AND POLYCYTHEMIA PATIENTS TREATED WITH P$sup 3$$sup 2$
THE INFLUENCE OF RADIOPHOSPHORUS THERAPEUTICS ON THE PERIPHERAL BLOOD IN THE CASE OF POLYCYTHEMIA AND EARLY IDENTIFICATON OF BLOOD-PICTURE ALTERATIONS